Silexion Therapeutics Corp Ordinary Shares

SLXN

Silexion Therapeutics Corp is a biopharmaceutical company focused on developing innovative therapies for rare and underserved diseases. The company leverages advanced research and development to create targeted treatments with the aim to improve patient outcomes.

$2.92 -0.10 (-3.23%)
🚫 Silexion Therapeutics Corp Ordinary Shares does not pay dividends

Company News

Silexion Therapeutics Receives Positive Feedback from German Health Authority on Design of Phase 2/3 Clinical Trial in Pancreatic Cancer
GlobeNewswire Inc. • Silexion Therapeutics Corp. • December 2, 2025

Silexion Therapeutics received formal written Scientific Advice from the German Federal Institute for Drugs and Medical Devices regarding its planned Phase 2/3 clinical trial for SIL204, a potential treatment for locally advanced pancreatic cancer. The guidance provides regulatory clarity and supports the company's planned trial initiation in Q2 ...

SLXNW
US Futures Point To Cautious Start As Investors Await Fed's Rate Decision: Tesla, Microsoft, Meta Among Stocks In Focus Ahead Of Earnings
Benzinga • Rishabh Mishra • January 29, 2025

U.S. stock futures were mixed ahead of the Federal Reserve's interest rate decision and key earnings reports from major tech companies. Investors are cautious as they await the Fed's policy announcement and guidance.

TSLAMSFTMETASBUXSYKSXTP

Related Companies

Sprott Silver Miners & Physical Silver ETF
SLVR
VanEck Steel ETF
VanEck Steel ETF
SLX
SPDR S&P 600 Small Cap Growth ETF (based on S&P SmallCap 600 Growth Index--symbol: CKG)
SPDR S&P 600 Small Cap Growth ETF (based on S&P SmallCap 600 Growth Index--symbol: CKG)
SLYG
Silexion Therapeutics Corp Warrant
Silexion Therapeutics Corp Warrant
SLXNW